CA2465274A1 - Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample - Google Patents

Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample Download PDF

Info

Publication number
CA2465274A1
CA2465274A1 CA002465274A CA2465274A CA2465274A1 CA 2465274 A1 CA2465274 A1 CA 2465274A1 CA 002465274 A CA002465274 A CA 002465274A CA 2465274 A CA2465274 A CA 2465274A CA 2465274 A1 CA2465274 A1 CA 2465274A1
Authority
CA
Canada
Prior art keywords
group
rna
cytoplasmic
combinations
accomplished
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002465274A
Other languages
English (en)
French (fr)
Inventor
Shawn Mark O'hara
Daniel Zweitzig
Brad Foulk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunivest Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2465274A1 publication Critical patent/CA2465274A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dentistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002465274A 2001-10-26 2002-10-28 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample Abandoned CA2465274A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33066901P 2001-10-26 2001-10-26
US60/330,669 2001-10-26
US36994502P 2002-04-04 2002-04-04
US60/369,945 2002-04-04
PCT/US2002/034397 WO2003035894A2 (en) 2001-10-26 2002-10-28 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample

Publications (1)

Publication Number Publication Date
CA2465274A1 true CA2465274A1 (en) 2003-05-01

Family

ID=26987390

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002465274A Abandoned CA2465274A1 (en) 2001-10-26 2002-10-28 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
CA002465288A Abandoned CA2465288A1 (en) 2001-10-26 2002-10-28 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002465288A Abandoned CA2465288A1 (en) 2001-10-26 2002-10-28 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample

Country Status (9)

Country Link
EP (2) EP1438398A2 (de)
JP (1) JP2005507997A (de)
KR (1) KR20040047971A (de)
CN (1) CN1610752A (de)
AU (1) AU2002360305A1 (de)
BR (1) BR0213520A (de)
CA (2) CA2465274A1 (de)
IL (1) IL161357A0 (de)
WO (2) WO2003035894A2 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US7318902B2 (en) 2002-02-04 2008-01-15 Colorado School Of Mines Laminar flow-based separations of colloidal and cellular particles
CA2500392C (en) 2002-09-27 2012-11-27 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
CA2542656A1 (en) * 2003-10-16 2005-05-06 Genomic Health, Inc. Qrt-pcr assay system for gene expression profiling
US7332597B2 (en) 2004-06-28 2008-02-19 University Of Kentucky Research Foundation Primers and probe to identify mycobacterium tuberculosis complex
ITBO20040420A1 (it) 2004-07-07 2004-10-07 Type S R L Macchina per taglio e formatura di piattine metalliche
DE102005013261A1 (de) * 2005-03-22 2006-09-28 Adnagen Ag Reagenz und Verfahren zur Verhinderung der zeitabhängigen Expression in biologischen Zellen
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
DE102005029808A1 (de) * 2005-06-27 2007-01-04 Siemens Ag Trägermaterial, Verfahren zu seiner Herstellung und Verwendung
ITBO20050481A1 (it) 2005-07-19 2007-01-20 Silicon Biosystems S R L Metodo ed apparato per la manipolazione e/o l'individuazione di particelle
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
KR101446626B1 (ko) 2005-09-02 2014-10-06 도레이 카부시키가이샤 신장암 진단, 신장암 환자 예후 예측을 위한 조성물 및 방법
US20070059683A1 (en) * 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
ES2886923T3 (es) 2005-09-20 2021-12-21 Menarini Silicon Biosystems Spa Métodos y composición para generar sondas de ADN de secuencia única, marcaje de sondas de ADN y el uso de estas sondas
US9134237B2 (en) 2005-09-20 2015-09-15 Janssen Diagnotics, LLC High sensitivity multiparameter method for rare event analysis in a biological sample
ITBO20050646A1 (it) 2005-10-26 2007-04-27 Silicon Biosystem S R L Metodo ed apparato per la caratterizzazione ed il conteggio di particelle
US9878326B2 (en) 2007-09-26 2018-01-30 Colorado School Of Mines Fiber-focused diode-bar optical trapping for microfluidic manipulation
US8119976B2 (en) 2007-07-03 2012-02-21 Colorado School Of Mines Optical-based cell deformability
US9885644B2 (en) 2006-01-10 2018-02-06 Colorado School Of Mines Dynamic viscoelasticity as a rapid single-cell biomarker
US9487812B2 (en) 2012-02-17 2016-11-08 Colorado School Of Mines Optical alignment deformation spectroscopy
ITTO20060226A1 (it) 2006-03-27 2007-09-28 Silicon Biosystem S P A Metodo ed apparato per il processamento e o l'analisi e o la selezione di particelle, in particolare particelle biologiche
EP2008102A4 (de) * 2006-04-18 2009-07-08 Wellstat Biologics Corp Detektion von proteinen aus zirkulierenden neoplastischen zellen
WO2007147074A2 (en) 2006-06-14 2007-12-21 Living Microsystems, Inc. Use of highly parallel snp genotyping for fetal diagnosis
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (de) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten
CN101583722A (zh) 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 从生物学样品检测稀有细胞的方法和组合物
JP4926812B2 (ja) * 2007-02-01 2012-05-09 シスメックス株式会社 血球分析装置および体液分析方法
US10722250B2 (en) 2007-09-04 2020-07-28 Colorado School Of Mines Magnetic-field driven colloidal microbots, methods for forming and using the same
ITTO20070771A1 (it) 2007-10-29 2009-04-30 Silicon Biosystems Spa Metodo e apparato per la identificazione e manipolazione di particelle
HUE031848T2 (en) 2008-09-20 2017-08-28 Univ Leland Stanford Junior Non-invasive diagnosis of fetal aneuploidy by sequencing
IT1391619B1 (it) 2008-11-04 2012-01-11 Silicon Biosystems Spa Metodo per l'individuazione, selezione e analisi di cellule tumorali
US10895575B2 (en) 2008-11-04 2021-01-19 Menarini Silicon Biosystems S.P.A. Method for identification, selection and analysis of tumour cells
CA2782123C (en) 2009-03-17 2017-05-02 Silicon Biosystems S.P.A. Microfluidic device for isolation of cells
JP5729904B2 (ja) 2009-06-02 2015-06-03 キヤノン株式会社 細胞から蛋白質、ｄｎａ、ｒｎａを調製する方法
WO2011034115A1 (ja) * 2009-09-17 2011-03-24 Jsr株式会社 アビジンとビオチン誘導体の解離方法及び解離剤
BR112012016451A2 (pt) * 2010-01-04 2020-09-08 Giagen Gaithersburg, INC. métodos, composições, e kits para recuperação de ácidos nucleicos ou proteínas de amostras de tecido fixadas
JP5871933B2 (ja) 2010-09-10 2016-03-01 バイオ−ラッド ラボラトリーズ インコーポレーティッド Ｄｎａ内のｒｎａ相互作用領域の検出
CN102565404B (zh) * 2010-12-24 2014-04-16 牛刚 一种检测血液中游离大肠癌细胞标志物的试剂盒
CN102156164B (zh) * 2011-01-13 2012-12-12 北京肿瘤医院 核仁磷酸蛋白可变剪接体的质谱鉴定方法和胃癌诊断试剂盒
CN102109525B (zh) * 2011-01-26 2013-10-16 牛刚 一种检测血液中游离乳腺癌细胞标志物的试剂盒
EP2675913B1 (de) 2011-02-15 2016-12-14 Bio-Rad Laboratories, Inc. Erkennung von methylierung in einer subpopulation von genomischer dna
US20120252038A1 (en) * 2011-04-01 2012-10-04 Chianese David A Steroid receptor assays
EP2739752B1 (de) * 2011-08-03 2017-07-19 Bio-Rad Laboratories, Inc. Filterung von kleinen nukleinsäuren anhand von permeabilisierten zellen
ITTO20110990A1 (it) 2011-10-28 2013-04-29 Silicon Biosystems Spa Metodo ed apparato per l'analisi ottica di particelle a basse temperature
ITBO20110766A1 (it) 2011-12-28 2013-06-29 Silicon Biosystems Spa Dispositivi, apparato, kit e metodo per il trattamento di un campione biologico
WO2014067528A1 (en) * 2012-10-29 2014-05-08 Arcedi Biotech Aps Improved enrichment and detection of rare blood cells
US9857361B2 (en) 2013-03-15 2018-01-02 Iris International, Inc. Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples
ES2658692T3 (es) * 2013-03-15 2018-03-12 Iris International, Inc. Método y composición para teñir y procesar una muestra de orina
EP3670664B1 (de) * 2014-02-28 2022-09-07 Gen-Probe Incorporated Verfahren zur isolierung von nukleinsäure aus proben in flüssigkeitsbasierten zytologischen konservierungsmitteln mit formaldehyd
US9771571B2 (en) 2014-02-28 2017-09-26 Gen-Probe Incorporated Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
US9771572B2 (en) 2014-02-28 2017-09-26 Gen-Probe Incorporated Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
JP2014158468A (ja) * 2014-03-05 2014-09-04 Clinical Genomics Pty Ltd 検出方法
SG10202104816QA (en) * 2015-02-10 2021-06-29 Illumina Inc Methods and compositions for analyzing cellular components
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
US10282588B2 (en) * 2016-06-09 2019-05-07 Siemens Healthcare Gmbh Image-based tumor phenotyping with machine learning from synthetic data
CN115119829B (zh) 2017-10-19 2024-07-12 斯特雷克股份有限公司 用于胞外囊泡的溶血和凝血调节以及稳定化的组合物
CN110456034B (zh) * 2018-05-07 2022-07-22 上海市第十人民医院 一种循环肿瘤细胞的检测方法
CN109402240B (zh) * 2019-01-08 2020-08-25 圣湘生物科技股份有限公司 核酸释放剂、核酸pcr扩增方法和pcr扩增试剂盒
KR102707636B1 (ko) * 2021-11-05 2024-09-20 고려대학교 세종산학협력단 머신러닝 기반의 렌즈프리 그림자 이미징 기술을 이용한 백혈병 진단 방법 및 장치
WO2023080601A1 (ko) * 2021-11-05 2023-05-11 고려대학교 세종산학협력단 머신러닝 기반의 렌즈프리 그림자 이미징 기술을 이용한 질병 진단 방법 및 장치
JP7757800B2 (ja) * 2022-01-14 2025-10-22 株式会社島津製作所 電気泳動システム、電気泳動装置、電気泳動解析方法、および、電気泳動解析プログラム
CN116042772B (zh) * 2023-02-10 2025-07-29 上海立闻生物科技有限公司 针对少量来自于新鲜样本的肿瘤细胞全转录组测序的方法和试剂盒
WO2025256538A1 (zh) * 2024-06-12 2025-12-18 北京沙砾生物医药股份有限公司 一种细胞产品中检测肿瘤残留的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929556A (en) * 1986-02-06 1990-05-29 The Dow Chemical Company Enzyme immobilization with polysulfonium salts
US5346994A (en) * 1992-01-28 1994-09-13 Piotr Chomczynski Shelf-stable product and process for isolating RNA, DNA and proteins
WO1998004689A1 (en) * 1995-07-31 1998-02-05 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
ATE471150T1 (de) * 1996-03-26 2010-07-15 Kopreski Michael S Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden
US6156564A (en) * 1996-06-07 2000-12-05 The United States Of America As Represented By The Department Of Health And Human Services Cellular apoptosis susceptibility protein (CSP) and antisense CSP
WO1999041613A1 (en) * 1998-02-12 1999-08-19 Immunivest Methods and reagents for the rapid and efficient isolation of circulating cancer cells
US6156515A (en) * 1999-02-09 2000-12-05 Urocor, Inc. Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
US6358697B2 (en) * 1999-04-21 2002-03-19 Children's Hospital Medical Center Intracellular pharmaceutical targeting

Also Published As

Publication number Publication date
AU2002360305A1 (en) 2003-05-06
WO2003035895A3 (en) 2004-01-08
WO2003035895A2 (en) 2003-05-01
BR0213520A (pt) 2006-05-23
KR20040047971A (ko) 2004-06-05
EP1438398A2 (de) 2004-07-21
WO2003035894A2 (en) 2003-05-01
CA2465288A1 (en) 2003-05-01
CN1610752A (zh) 2005-04-27
IL161357A0 (en) 2004-09-27
WO2003035894A3 (en) 2003-12-04
EP1438419A2 (de) 2004-07-21
JP2005507997A (ja) 2005-03-24
WO2003035894A8 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
US20060008807A1 (en) Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
CA2465274A1 (en) Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
JP5763545B2 (ja) ホルマリン固定組織からの種々の生体分子の並行抽出
EP2385993B1 (de) Genetische analyse von zellen
EP2638176B1 (de) Anreicherung und identifizierung fetaler zellen in maternalem blut und liganden für eine solche verwendung
KR20150030655A (ko) 압타머-기반 다중 검정법
EP3371594A1 (de) Repräsentative diagnose
EP1488007A1 (de) Verlaufsdarstellung der genexpression in bioptischen tumorgeweben
WO2016154600A1 (en) Digital analysis of circulating tumor cells in blood samples
EP3358020B1 (de) Diagnostisches testsystem für spezifische, sensible und reproduzierbare detektion von zirkulierenden nukleinsäuren in vollblut
CN107109699B (zh) 与胎儿绒毛外滋养层细胞测定有关的方法和组合物
CN108059649A (zh) 蛋白组基因组分析系统和方法
US10161005B2 (en) Method for detecting telomerase via washing-free anchored-extension and telomeric-binding amplification, and kit
CN117947036A (zh) 特异性结合卵巢癌相关中性粒细胞的核酸适配体及其用途
AU2002360316A1 (en) Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
EP3385392A1 (de) Verfahren zur analyse der expression von einem oder mehreren biomarker-rna-molekülen
WO2009056339A1 (en) Means and methods for the detection and isolation of fetal and embryonic cells and nucleic acid from maternal body fluid
KR20220065555A (ko) 엑소좀 유래 miRNA를 이용한 아토피성 피부염 상관 스트레스 진단기술
EP3268476B1 (de) Oligonukleotidsonden und verwendungen davon
EP2948750A1 (de) Rt-qpcr-analyse von mikroseziertem material aus gefärbtem ffpet-schnitt
CN110257521A (zh) miRNA-30a及其靶基因在肺癌检测中的应用
WO2007043418A1 (ja) 肺腺癌患者の術後予後を予測するための方法及び組成物
WO2025256538A1 (zh) 一种细胞产品中检测肿瘤残留的方法
CN117721186A (zh) 一种低丰度lncRNA的RT-qPCR检测方法
HK1148032B (en) Gene expression profiling in biopsied tumor tissues

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20061030

P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: T-6-6-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20250217